✨
AI Summary
- Sanjeev Luther on Ernexa's engineered iMSCs for cancer and autoimmune disease.
- Advances cell therapy using synthetic, standardized, off-the-shelf iMSCs.
- Aims to overcome historic hurdles in mesenchymal stem cell therapy.
Guests on This Episode
SL
Sanjeev Luther
1 podcast appearance